Andmed seisuga: 22.07.2024 17:11 (GMT+3)
TALLINNA FARMAATSIATEHAS
BALANCE SHEET
BALANCE SHEET, AS AT 30.06.2001
Consolidated/unaudited
in thousand EEK 31.12.2000 30.06.2001
A S S E T S
CURRENT ASSETS
Cash and bank accounts 715 251
Customer receivables
ACCOUNTS RECEIVABLE 4,979 2,899
ALLOWANCE FOR DOUBTFUL RECEIVABLES
RESERVE - -
Total 4,979 2,899
Other receivables
RECEIVABLES FROM PARENT COMPANY 30,375 26,517
OTHER SHORT-TERM RECEIVABLES 98 111
Total 30,473 26,628
Accrued income 37 37
Prepaid expenses 582 319
Inventories
RAW MATERIAL 12,134 9,105
WORK-IN-PROGRESS 565 328
FINISHED GOODS 11,654 17,558
PREPAYMENTS TO SUPPLIERS 1,331 987
Total 25,684 27,979
TOTAL CURRENT ASSETS 62,471 58,114
NON-CURRENT ASSETS
Long-term investments 449 449
Fixed assets
FIXED ASSETS IN NET BOOK VALUE 33,636 32,718
CONSTRUCTION IN PROGRESS 119 1,750
Total 33,755 34,468
Intangible assets 3,216 3,084
TOTAL NON-CURRENT ASSETS 37,420 38,001
TOTAL ASSETS 99,891 96,115
LIABILITIES AND SHAREHOLDERS’ EQUITY
LIABILITIES
CURRENT LIABILITIES
CURRENT PORTION OF LONG-TERM DEBT 7,703 5,135
SHORT-TERM BANK LOANS 496 254
Total 8,200 5,390
Customers prepayments - -
Accounts payable 13,714 9,825
Other payables 3,882 1,981
Taxes payable 701 1,119
Accrued expenses 2,364 1,503
TOTAL CURRENT LIABILITIES 28,860 19,819
NON-CURRENT LIABILITIES
Long-term debt obligations
BANK LOANS 24,055 24,055
PAYABLES TO PARENT COMPANY 24,351 24,351
TOTAL NON-CURRENT LIABILITIES 48,406 48,406
TOTAL LIABILITIES 77,266 68,225
SHAREHOLDERS’ EQUITY
SHARE CAPITAL 12,500 12,500
RESERVES 2,316 2,316
RETAINED EARNINGS
(ACCUMULATED DEFICIT) -2,779 7,808
PROFIT (LOSS) FOR FINANCIAL YEAR 10,587 5,266
SHAREHOLDERS’ EQUITY TOTAL 22,625 27,891
LIABILITIES AND SHAREHOLDERS’ EQUITY 99,891 96,115
Raivo Unt
Financial Director
+372 612 0201
Sisukaart